Search Results

But your GPCR program still isn't moving at the pace it should. The GPCR Data Dilemma: The Lego Bucket Problem I've seen promising GPCR programs generate massive volumes GPCR As the co-founder of Dr. GPCR, we've built a global hub connecting over 1,300 GPCR scientists dedicated to this field. Ready to Move Your GPCR Program Forward?

Sharpen your discovery decisions ➤ Yamina’s Corner - The Hidden Cost of Busy A GPCR program can collapse—not Read the article now ➤ Discovery on Target - The Next Wave of GPCR Drug Discovery The 20th Annual GPCR-Based Drug Discovery Conference  isn’t just another event—it’s where the frameworks shaping the next decade GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need Aside from his vast experience in drug development, not to mention his extensive publication record,

The Overlooked Step in Every Discovery Program So what does that mean for discovery scientists designing the next generation of GPCR ligands? By visualizing enzymes as dynamic molecular partners rather than static filters, drug discovery scientists Kenakin live for an open Q&A session designed for discovery scientists. That’s where Terry’s Corner  gives discovery teams an edge.

In the high-stakes world of GPCR drug discovery , breakthrough science isn't enough. GPCR, we recognized this core problem. The Role of Systems Thinking in GPCR Drug Discovery Systems thinking is the intentional practice of seeing I'll show you how to transform your drug discovery process from a series of disconnected efforts into is strategic and sustainable, offering precision scientific and operational guidance  to accelerate discovery

Why Speed Matters in GPCR Drug Discovery Nine out of ten GPCR programs stall  not because the target In accelerating GPCR drug discovery, the bottleneck isn’t target identification — it’s turning validated That’s exactly what Terry’s Corner  was built to do: bring four decades of frontline discovery insight How CRO Communication Impacts GPCR Drug Development Success Even the best science falters without operational For scientists in discovery, this means two things: Technical clarity drives survival.

on Target GPCR Drug Discovery. 🔍 This Week in Premium: Sneak Peek A curated preview of this week’s Upcoming events:  5th MMCS New Trends in Drug Discovery; GPCR-UK Network Meeting; neuroGPCR Symposium Terry’s Corner: Why Binding Kinetics Matter More Than Affinity In drug discovery today, time wasted is Discovery on Target GPCR-Based Drug Discovery  meeting is where the next wave of therapies—from allosteric GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who

Every delay in the discovery pipeline compounds into wasted years, lost opportunities, and soaring costs For drug hunters working at the GPCR interface, the difference between a successful lead and a dead-end For GPCR drug discovery, those hidden details can determine whether a compound advances or stalls. For discovery teams, this isn’t an academic exercise. Pipeline Payoff: Assay Sensitivity for Better Predictions For drug discovery scientists, time and predictive

Terry's Corner – Assay Volume Control in GPCR Drug Discovery This week in Terry’s Corner, you’ll learn drug discovery program. Your membership gives you:   Proven   frameworks  for real-world GPCR drug discovery Flexible , on-demand drug discovery. Journey: How Decades of Discovery Shaped pHSense From HTRF to pHSense: The Long Game of GPCR Innovation

GPCR research requires turning data into insights for drug discovery Hi GPCR Friends, Every week, critical Terry's Corner – Curve Shifts Don’t Lie, But Your Eyes Might In early drug discovery, “those curves look Understand how AI/ML and GPCR biology meet to unlock safer drugs. When the global biotech crowd lands in Boston for Discovery on Target. GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

GPCR and global experts at the GPCR Drug Discovery session during Discovery on Target 2025—where groundbreaking GPCR Drug Discovery at Discovery on Target 2025 — The Track You Can’t Miss If you work in drug discovery And at this year’s Discovery on Target  meeting in Boston, the GPCR Drug Discovery track will deliver 2025 🎯 Track:   GPCR Drug Discovery Let’s connect. Let’s move GPCR drug discovery forward — together. 🚨 Mark your calendar for the GPCR Happy Hour Join

For drug discovery teams and scientists, staying ahead requires more than just reading papers—it demands research and drug discovery right now. Terry's Corner : Unlock the Power of Intracellular GPCR Drugs For years, GPCR drug discovery has focused GPCR Podcast : The Future of GPCR Drug Discovery with Molecular Modeling The field of GPCR research is GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who

space focused on GPCR pharmacology. GPCR Updates Learn Pharmacology That Drives Discovery  – From Dr. GPCR Podcast appearance. oncogenic signaling in lymphoid neoplasms, and its disruption boosts sensitivity to the apoptosis-inducing drug GPCR Team

Hiring Won’t Save Your GPCR Drug Discovery Program When a drug discovery program stalls, the default Bad Data Management Is Undermining Your GPCR Drug Discovery Team The real problem isn’t competence. Without a unified drug discovery data management  pipeline, teams waste hours cleaning, reconciling, Build Precision Systems for GPCR Drug Discovery The only way out for GPCR drug discovery programs isn Because the truth is harsh: in drug discovery, you don’t run out of science. You run out of money.

GPCR – Precision Tools for GPCR Assays Dr. GPCR and Celtarys Research have teamed up. The goal is to accelerate receptor-targeted discovery. Explore the partnership Multiplexing GPCR Discovery - Sakmar Lab’s Toolkit Goes Public The latest podcast It’s exciting to see how the GPCR field is evolving. GPCR Team

The integration of AI in GPCR drug discovery has the potential to accelerate the identification and development Artificial intelligence in GPCR drug discovery The use of AI in GPCR drug discovery has increased over Greater application of unsupervised machine learning: most applications of ML in GPCR drug discovery Instead, it complements and assists researchers in the GPCR drug discovery process. drug discovery.

Is Your GPCR Program Slowing Down—Even With Good Data? You’re not alone. Meetings drag. Decisions stall. And momentum quietly dies. GPCR Ecosystem. Strong science. Promising data. But no systems to turn it into momentum. GPCR, I’m connected to 1,300+ scientists and decision-makers worldwide. Who I Work With ✅ Biotech Teams  – Especially those lacking in-house GPCR leads or overwhelmed by CRO

GPCRs continue to be regarded as one of the most tractable classes of drug targets and are targeted by 30%–40% of current drugs (Hauser et al., 2017), with annual sales of GPCR-targeting drugs in 2018 accounting Despite this high number of GPCR targeted drugs, only a small portion (∼110) of the human GPCRome (consisting of approximately 850 GPCRs) has been successfully drugged, and obtaining highly potent and selective Read more at the source #DrGPCR #GPCR #IndustryNews

drugs in treating a range of health conditions, from cancer and genetic disorders to inflammation and to that star are Verily and Sosei Heptares, which have struck a research agreement to discover new GPCR targets that’ll fuel the development of potential drug candidates. drug discovery have clocked in at $1 billion—with Genentech—and, just last November, $2.6 billion in Read more at the source #DrGPCR #GPCR #IndustryNews

Target-based screening is now a fundamental pillar of drug development, and GPCRs are key targets for This makes them very useful for GPCR drug discovery, since receptors are a lot bigger than their small Optimizing GPCR Drug Discovery with Fluorescence Polarization: Key Advantages and Future Perspectives Contact us  to drive further advancements in GPCR drug discovery!   Target-based drug discovery: Applications of fluorescence techniques in high throughput and fragment-based

Pipeline Efficiency Begins With the Chemistry Itself Drug discovery pipelines often stall not because This lesson asks a deceptively simple question: What if our molecules—not our targets—are limiting discovery early history of drug discovery was rooted in nature . Allostery and Biased Signaling Change the Game The most profound change in GPCR drug discovery is our Members can also propose new topics, ensuring relevance to real-world discovery problems.

In his view, collaboration is not a bonus or an optional supplement—it is the only way GPCR drug discovery ligand discovery today.   Many startups chase elaborate simulations that look impressive on paper but do little to move drug discovery discovery. Carlsson’s lesson is simple but profound: the strongest model in GPCR drug discovery isn’t built on a

Innovative Approaches in GPCR Drug Discovery: Designing Precise Solutions for GPCR Challenges. Career opportunities:  Discovery biology roles and training paths in GPCR signaling. What You’ll Learn on molecular creativity in drug discovery: • Why Nature Was First : From opium to antibiotics Michelle Halls dissects how spatial GPCR signaling shifts discovery—and how leadership, mentorship, and GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who

Are you ready to truly understand how pharmacologists predict whole-body drug response from a single Probability Models   This is practical drug development expertise from Terry’s 40+ years of experience GPCR News.   Elevate your pharmacology expertise. Unlock "Pharmacologic Models" now

Hello GPCR Trailblazers, This week, we’re spotlighting Celtarys Research, our newest partner, featured Maria Majellaro, highlighting their fluorescent ligand tools for live-cell GPCR assays.   Explore Terry's Corner From Chemistry Lab to GPCR Partner – New Podcast with Celtarys Dr. discovery. GPCR Team

Emerging GPCR Therapeutic Targets in CNS Drug Discovery GPCRs have been studied for decades, but there Orphan GPCRs in Neurodegenerative Disorders: Integrating Structural Biology and Drug Discovery Approaches for the success of drug discovery, just as much as choosing the right targets. Their integration into drug discovery neuroscience workflows helps accelerate GPCR target identification Orphan GPCRs in Neurodegenerative Disorders: Integrating Structural Biology and Drug Discovery Approaches

In GPCR drug discovery, a single mistaken assumption can derail an entire program. Why Misreading Antagonism Delays GPCR Drug Discovery If a dose-response curve shifts to the right, you Unlock “Competitive Antagonism” Now Only in Terry’s Corner Why Terry’s Corner For discovery-phase teams hunters Influence over upcoming topics Who it’s for:  drug discovery teams, pharmacologists refining Why now:  GPCR research is accelerating—and the projects that succeed will be those built on clear, accurate

of GPCR research and drug discovery. , drug discovery, and biophysics, ensuring you don't miss crucial networking and learning opportunities Terry's Corner - Unlock the Power of Target Residence Time in Your GPCR Drug Discovery Pipeline Gain , and business moves shaping drug discovery. GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

Enhancing scientific exploration by concentrating on understanding inhibition to advance GPCR drug discovery This Week’s GPCR Intelligence: Every drug you design will meet an enzyme before it meets its receptor Terry's Corner – How Enzyme Inhibition Shapes Every Discovery Program Every molecule meets an enzyme Mastering inhibition isn’t just about avoiding drug–drug interactions. GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

Elevate Your GPCR Science with Essential Frameworks for Precision Drug Discovery: An Insight into Advanced , Not Breakdowns In the fast-paced world of GPCR drug discovery, the "go fast" mindset can often lead GPCR-Based Drug Discovery conference is where the future of GPCR therapies will be defined. GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who Keywords: GPCR, drug discovery, pharmacology, antagonism, competitive, non-competitive, Terry's Corner

This lecture is a roadmap for understanding why two drugs with similar affinity may behave completely Allosteric Thinking Changes the Game in Drug Discovery For decades, drug discovery pipelines have relied But without understanding how GPCR state changes  influence that affinity—or vice versa—drug discovery Terry’s Pharmacology Corner  delivers trusted, razor-sharp insight to help drug discovery professionals Ask-Me-Anything sessions A growing, curated on-demand library Opportunities to shape future topics Built for discovery-phase